RecruitingNot ApplicableNCT07427901

Quality Of Life In Colorectal Cancer Survivors

Sponsor

Institute of Oncology Ljubljana

Enrollment

368 participants

Start Date

May 1, 2023

Study Type

INTERVENTIONAL

Conditions

Colorectal, Cancer Colon Cancer Rectal Cancer

Summary

The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

Patients with colorectal cancer (colon or rectal cancer)
Age 25 to 65 years
First oncological treatment performed at the Institute of Oncology Ljubljana
Working-capable patients
Ability to complete questionnaires
Ability to provide written informed consent

Exclusion Criteria4

Age \< 25 years or \> 65 years
Patients unable to complete questionnaires
Patients unable to participate in follow-up assessments
Patients who do not provide written informed consent

Interventions

OTHERQuality of Life Assessment

Quality of life assessment using questionnaires at 6, 12, and 24 months after oncological treatment.

Locations(1)

Institute of Oncology Ljubljana

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07427901

Related Trials

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

NCT0697316127 locations

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

NCT069922589 locations